RESEARCH ARTICLE – Pharmaceutics, Drug Delivery and Pharmaceutical Technology Analytical Methods for the Evaluation of Melamine Contamination STUART L. CANTOR, ABHAY GUPTA, MANSOOR A. KHAN Division of Product Quality Research, Office of Pharmaceutical Science, Food and Drug Administration, Silver Spring, Maryland 20993-0002 Received 26 August 2013; revised 4 November 2013; accepted 13 November 2013 Published online 10 December 2013 in Wiley Online Library (wileyonlinelibrary.com). DOI 10.1002/jps.23812 ABSTRACT: There is an urgent need for the analysis of melamine in the global pharmaceutical supply chain to detect economically motivated adulteration or unintentional contamination using a simple, nondestructive analytical technique that confirms the extent of adulteration in a shorter time period. In this work, different analytical techniques (thermal analysis, X-ray diffraction, Fourier transform infrared (FT-IR), FT-Raman, and near-infrared (NIR) spectroscopy) were evaluated for their ability to detect a range of melamine levels in gelatin. While FT-IR and FT-Raman provided qualitative assessment of melamine contamination or adulteration, powder X-ray diffraction and NIR were able to detect and quantify the presence of melamine at levels as low as 1.0% w/w. Multivariate analysis of the NIR data yielded the most accurate model when three principal components were used. Data were pretreated using standard normal variate transformation to remove multiplicative interferences of scatter and particle size. The model had a root-mean-square error of calibration of 2.4 (R 2 = 0.99) and root-mean square error of prediction of 2.5 (R 2 = 0.96). The value of the paired t test for actual and predicted samples (1%–50% w/w) was 0.448 (p < 0.05), further indicating the robustness of the model. Published 2013. This article is a U.S. Government work and is in the public domain in the USA 103:539–544, 2014 Keywords: melamine; gelatin; near-infrared spectroscopy (NIRS); chemometrics; partial least squares; PLS; FTIR; infrared spectroscopy; Raman spectroscopy; X-ray diffractometry INTRODUCTION The global nature of pharmaceutical supply makes contamina- tion of pharmaceutical ingredients of prime importance. Prod- uct adulteration with melamine is a serious public health con- cern as it is a known nephrotoxin. 1 Economically motivated melamine contamination of various products has been in the spotlight for the past several years owing to a series of highly publicized incidents. Besides the pet food recalls in the United States in 2007, China reported in 2008 adulteration of milk, infant formula, and other milk-derived products that affected over 300,000 infants worldwide. 2 Melamine is an industrial chemical used in the manufacturing of resins for surface lam- inates and adhesives in the production of wood-based panels. Melamine or its resins are also used in the manufacture of dinnerware, additives for textiles, and as flame-retardant in foam mattresses. Hence, analytical methodologies are needed to rapidly detect the presence of intentional adulteration or unintentional contamination from melamine. Melamine or 2,4,6-triamino-s-triazine (Fig. 1) is a white crys- talline solid with a molecular weight of 126.12 g/mol. Melamine has a pK a of 5.35 at 25 ◦ C and its solubility has been reported to be 3.24 mg/mL at 20 ◦ C. 3,4 The Merck index reports the melting point of melamine as <250 ◦ C while Hawley’s condensed chem- ical dictionary reports it as 354 ◦ C. 5,6 Mast et al. reported the elimination half-life of melamine as 2.7 h and the renal clear- ance as 2.5 mL/min. Following oral administration of 250 mg/kg melamine to rats, 50% of the parent compound was excreted in Correspondence to: Mansoor A. Khan (Telephone: +301-796-0016; Fax: +301- 796-9816; E-mail: Mansoor.khan@fda.hhs.gov) The findings and conclusions in this article have not been formally dissem- inated by the Food and Drug Administration and should not be construed to represent any Agency determination or policy. Journal of Pharmaceutical Sciences, Vol. 103, 539–544 (2014) Published 2013. This article is a U.S. Government work and is in the public domain in the USA Figure 1. Chemical structure of melamine. the urine in less than 6 h. LD 50 , the lethal dose of a compound that would result in death in 50% of the tested animals, in rats has been reported as 3.2 g/kg body weight. 7 In 2007, the Food and Drug Administration (FDA) pub- lished a guidance titled “Pharmaceutical Components at Risk for Melamine Contamination” which listed 23 components con- sidered to be at risk for melamine contamination. 8 Gelatin is one of the pharmaceutical components on this list that may be vulnerable to melamine contamination as it is the main com- ponent in both hard and soft gelatin capsules. This inclusion is based upon the fact that gelatin has a high protein (nitrogen) content (98%–99% protein on dry weight basis), and the possi- bility exists that adulteration could be economically motivated as melamine is inexpensive and also has a very high nitrogen content of 66.6% by mass. Companies assaying for only nitro- gen content would not be able to distinguish between melamine and the desired protein. FDA has also developed and published a gas chromatography–mass spectrometry (GC–MS) method to screen for the presence of melamine and some related ana- logues in a variety of matrices at a minimum reporting level (MRL) of 10 : g/g or more, and guidance to extend the MRL Cantor, Gupta, and Khan, JOURNAL OF PHARMACEUTICAL SCIENCES 103:539–544, 2014 539